Tacrolimus in Pregnancy

ConditionsUnbound Tacrolimus in Pregnant Uterus Transplant Recipients Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-50

SponsorBaylor Research Institute

About this trial

To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.

Eligibility criteria

Qualifiers

Uterus transplant recipient

18 to 50 years of age

receiving tacrolimus for immunosuppression.

Disqualifiers

Individuals who have not had a uterine transplant

individuals over 50 years old

Trial design

Treatments tested in this trial

Modeling of unbound and whole blood tacrolimus in pregnant uterus transplant recipients

Treatment groups

55 Participants

are divided into 1 treatment group

Sponsors and collaborators

Baylor Research Institute

Lead sponsor

Children's Hospital Medical Center, Cincinnati

Collaborator

University of Washington

Collaborator

Source ClinicalTrials.gov